Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy

Grossmann, M; Hamilton, EJ; Gilfillan, C; Bolton, D; Joon, DL; Zajac, JD

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy

Version 2 2024-06-12, 15:09

Version 1 2022-06-08, 08:31

journal contribution

posted on 2024-06-12, 15:09 authored by M Grossmann, EJ Hamilton, C Gilfillan, D Bolton, DL Joon, JD Zajac

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy

History

Journal

Medical Journal of Australia

Volume

194

Pagination

301-306

Location

Australia

Publisher DOI

https://doi.org/10.5694/j.1326-5377.2011.tb02979.x

ISSN

0025-729X

eISSN

1326-5377

Language

English

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

6

Publisher

AUSTRALASIAN MED PUBL CO LTD

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine RANDOMIZED CONTROLLED-TRIAL ZOLEDRONIC ACID MINERAL DENSITY FRACTURE RISK POSITION STATEMENT CARDIOVASCULAR MORBIDITY INDUCED OSTEOPOROSIS ARTERIAL STIFFNESS INSULIN-RESISTANCE BODY-COMPOSITION

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports